Tenet Healthcare EVP Maloney reports equity holdings

Tenet Healthcare Corp executive vice president of corporate development Michael T. Maloney filed an initial ownership report showing his equity holdings as of February 27, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Tenet Healthcare Corp executive vice president of corporate development Michael T. Maloney filed an initial ownership report showing his equity holdings as of February 27, 2026. The filing lists common stock, performance stock options, and multiple tranches of time-based restricted stock units.

He directly holds common stock and performance stock options from February 2018 and February 2019, along with unvested restricted stock units granted in February 2024, February 2025, and February 2026. The restricted stock units are settled in Tenet common shares upon vesting, with vesting dates running from February 24, 2027 through February 27, 2029. The filing does not show any new purchases or sales, only existing holdings and vesting schedules.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Maloney Michael T.

Role EVP, Corporate Development

Type	Security	Shares	Price	Value
holding	2018 February Performance Stock Options (Right to Buy)	--	--	--
holding	2019 February Performance Stock Options (Right to Buy)	--	--	--
holding	2024 February Restricted Stock Units	--	--	--
holding	2025 February Restricted Stock Units	--	--	--
holding	2026 February Restricted Stock Units	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: 2018 February Performance Stock Options (Right to Buy) — 18,876 contracts (Direct); 2019 February Performance Stock Options (Right to Buy) — 18,682 contracts (Direct); 2024 February Restricted Stock Units — 3,737 contracts (Direct); 2025 February Restricted Stock Units — 5,068 contracts (Direct); 2026 February Restricted Stock Units — 5,013 contracts (Direct); Common Stock — 101,990 shares (Direct)

Footnotes (4)

F1. Represents unvested February 2024 time-based restricted stock units that vest in full on February 28, 2027.
F2. Restricted stock units are settled in shares of the Company's common stock upon vesting.
F3. Represents unvested February 2025 time-based restricted stock units that vest in equal remaining increments on February 24, 2027, and February 24, 2028.
F4. Represents unvested February 2026 time-based restricted stock units that vest in one-third increments on February 27, 2027, February 27, 2028, and February 27, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Tenet Healthcare (THC) Form 3 filing for Michael T. Maloney show?

The Form 3 shows Michael T. Maloney’s existing equity holdings in Tenet Healthcare, including common stock, performance stock options, and unvested restricted stock units. It is an initial ownership report and does not reflect new purchases or sales, only positions and vesting schedules.

How many Tenet Healthcare common shares does Michael T. Maloney report on Form 3?

Michael T. Maloney reports direct ownership of 101,990 shares of Tenet Healthcare common stock as of February 27, 2026. This figure appears alongside his option grants and restricted stock units and represents his baseline common share position at that reporting date.

What restricted stock units does Michael T. Maloney hold in Tenet Healthcare (THC)?

He holds February 2024, 2025, and 2026 restricted stock units totaling 3,737, 5,068, and 5,013 units, respectively. These are time-based awards that vest on specified future dates, with each unit settling in shares of Tenet’s common stock upon vesting.

When do Michael T. Maloney’s Tenet Healthcare restricted stock units vest?

The February 2024 restricted stock units vest in full on February 28, 2027. The February 2025 units vest in equal remaining increments on February 24, 2027 and February 24, 2028, while the February 2026 units vest in one-third increments from 2027 through 2029.

Are Maloney’s Tenet Healthcare restricted stock units settled in cash or stock?

The Form 3 states that Maloney’s restricted stock units are settled in shares of Tenet Healthcare’s common stock upon vesting. This means that, as each award vests on its scheduled dates, he will receive company shares rather than a cash payment.

Does the Tenet Healthcare (THC) Form 3 indicate insider buying or selling by Michael T. Maloney?

No, the Form 3 does not indicate insider buying or selling. All listed entries are classified as holdings with unknown transaction codes, reflecting existing positions in common stock, stock options, and restricted stock units rather than newly executed purchase or sale transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/09/2026 - 08:00 PM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Maloney Michael T.

(Last)

(First)

(Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS

75254

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/27/2026

3. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Corporate Development

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	101,990	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
2018 February Performance Stock Options (Right to Buy)	02/28/2021	02/28/2028	Common Stock	18,876	$20.6	D
2019 February Performance Stock Options (Right to Buy)	02/24/2026	02/27/2029	Common Stock	18,682	$28.26	D
2024 February Restricted Stock Units	⁽¹⁾	⁽¹⁾	Common Stock⁽²⁾	3,737	⁽²⁾	D
2025 February Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock⁽²⁾	5,068	⁽²⁾	D
2026 February Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock⁽²⁾	5,013	⁽²⁾	D

Explanation of Responses:

1. Represents unvested February 2024 time-based restricted stock units that vest in full on February 28, 2027.

2. Restricted stock units are settled in shares of the Company's common stock upon vesting.

3. Represents unvested February 2025 time-based restricted stock units that vest in equal remaining increments on February 24, 2027, and February 24, 2028.

4. Represents unvested February 2026 time-based restricted stock units that vest in one-third increments on February 27, 2027, February 27, 2028, and February 27, 2029.

	Chad J. Wiener, as Attorney-in-Fact for Michael T. Maloney	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR